Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal abnormalities in sickle cell disease.

P T Pham1, P C Pham, A H Wilkinson

  • 1Division of Nephrology, Kidney and Pancreas Transplantation, Departmentof Medicine, University of California at Los Angeles, School of Medicine, Los Angeles, California, USA.

Kidney International
|January 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reuse of a living donor kidney: A case study.

Human immunology·2026
Same author

Variations in provider practices in remote patient monitoring on peritoneal dialysis in the USA and Canada.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2024
Same author

<i>Candida glabrata</i> PD-Associated Peritonitis: A Case Report.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2018
Same author

Are patients prepared to use telemedicine in home peritoneal dialysis programs?

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2013
Same author

Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2013
Same author

Adult peritoneal dialysis patient with Tenckhoff and percutaneous endoscopic gastrostomy catheters.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2011

Sickle cell nephropathy damages kidneys through reduced blood flow and tissue death. Research reviews kidney disorders and treatments to slow disease progression.

Area of Science:

  • Nephrology
  • Hematology
  • Vascular Biology

Background:

  • Sickle cell nephropathy is a common complication of sickle cell disease.
  • Pathological changes include sickled erythrocytes, medullary ischemia, and papillary necrosis.
  • Manifestations include impaired urinary concentration, acidification, hematuria, and potassium secretion abnormalities.

Purpose of the Study:

  • To review glomerular and tubular disorders in sickle cell nephropathy.
  • To discuss therapeutic strategies for slowing disease progression.
  • To highlight the need for further research into pathogenic mechanisms and treatments.

Main Methods:

  • Historical review of literature on sickle cell nephropathy.
  • Analysis of studies on pathogenic mechanisms, including nitric oxide synthesis and hemodynamic factors.

Related Experiment Videos

  • Examination of outcomes in end-stage renal disease (ESRD) and renal transplantation.

    • Main Results:

    • Sickle cell nephropathy leads to proteinuria, nephrotic syndrome, and acute or chronic renal failure.
    • Nitric oxide synthesis and hemodynamic factors may play a role in disease progression.
    • Patients with ESRD from sickle cell nephropathy have survival and graft survival rates comparable to non-diabetic ESRD patients.

    Conclusions:

    • Sickle cell nephropathy involves complex glomerular and tubular damage.
    • Therapeutic interventions are crucial for managing disease progression.
    • Further research is essential to fully understand and treat sickle cell nephropathy.